A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A 24‐week double‐blind placebo‐controlled study of the efficacy and safety of the AMPA modulator S47445 in patients with mild to moderate Alzheimer's disease and depressive symptoms

Published:2019-01 Issue:1 Volume:5 Page:231-240
ISSN:2352-8737
Container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions
language:en
Short-container-title:Alzheimer's & Dementia: Translational Research & Clinical Interventions

Author:

Bernard Katy¹,Gouttefangeas Sylvie¹,Bretin Sylvie¹,Galtier Stéphanie¹,Robert Philippe²,Holthoff‐Detto Vjera³,Cummings Jeffrey⁴,Pueyo Maria¹

Affiliation:

1. Institut de Recherches Internationales Servier (IRIS)Suresnes CedexFrance

2. CoBTeK IA lab, Memory CenterUniversité Côte d'azurNiceFrance

3. Alexianer Krankenhaus Hedwigshöhe 112526BerlinGermany

4. Department of Brain Sciences, Cleveland Clinic Lou Ruvo Center for Brain HealthUniversity of Nevada Las VegasLas VegasNVUSA

Funder

Servier

Institut de Recherches Internationales

Publisher

Wiley

Subject

Psychiatry and Mental health,Neurology (clinical)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.trci.2019.04.002

Reference41 articles.

1. Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium

2. Depression in Alzheimer’s disease: overview and treatment

3. Mental and Behavioral Disturbances in Dementia: Findings From the Cache County Study on Memory in Aging

4. Prevalence of Neuropsychiatric Symptoms in Alzheimers Disease and Vascular Dementia

5. Trajectories of depressive symptoms and their relationship to the progression of dementia

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AMPA receptor neurotransmission and therapeutic applications: A comprehensive review of their multifaceted modulation;European Journal of Medicinal Chemistry;2024-02

2. Converged avenues: depression and Alzheimer’s disease– shared pathophysiology and novel therapeutics;Molecular Biology Reports;2024-01-28

3. Targeting synapse function and loss for treatment of neurodegenerative diseases;Nature Reviews Drug Discovery;2023-11-27

4. Targeting impaired nutrient sensing via the sirtuin pathway with novel compounds to prevent or treat dementia: A systematic review;Ageing Research Reviews;2023-09

5. Bridging rapid and sustained antidepressant effects of ketamine;Trends in Molecular Medicine;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3